Medtronic plc (MDT)

MDT Balance Sheet

Assets, liabilities, and equity analysis

MDT Quarterly Balance Sheet (USD)

Quarterly Report	TTM	04/24/2026	01/23/2026	10/24/2025	07/25/2025	04/30/2025	04/25/2025	01/24/2025	10/25/2024
Total Current Assets	—	—	24.071B	23.996B	23.223B	—	23.814B	22.513B	22.438B
Cash & Cash Equivalents	—	—	1.147B	1.282B	1.273B	—	2.218B	1.240B	1.394B
Short-Term Investments	—	—	7.236B	7.045B	6.848B	—	6.747B	6.682B	6.595B
Cash & Short-Term Investments	—	—	8.383B	8.327B	8.121B	—	8.965B	7.922B	7.989B
Accounts Receivable	—	—	87.000M	6.389B	6.263B	—	6.515B	6.115B	6.260B
Inventory	399.000M	399.000M	-803.000M	6.156B	-373.000M	186.000M	5.476B	5.610B	5.479B
Total Assets	—	—	91.485B	91.346B	90.972B	—	91.680B	89.973B	90.042B
Property, Plant & Equipment	—	—	-1.416B	7.164B	-504.000M	—	6.837B	6.593B	6.438B
Goodwill	—	—	41.892B	41.811B	42.007B	—	41.737B	40.819B	41.161B
Intangible Assets	—	—	10.335B	10.770B	11.223B	—	11.667B	12.185B	12.424B
Long-Term Investments	—	—	1.384B	0.00	0.00	—	0.00	0.00	0.00
Total Current Liabilities	—	—	9.495B	9.935B	11.530B	—	12.879B	11.840B	12.195B
Accounts Payable	—	—	2.569B	2.581B	2.555B	—	2.449B	2.286B	2.376B
Short-Term Debt	—	—	191.000M	1.420B	2.430B	—	2.868B	2.622B	3.719B
Total Liabilities	—	—	42.289B	42.489B	42.839B	—	43.424B	40.358B	41.326B
Long-Term Debt	—	—	27.880B	27.680B	26.128B	—	25.590B	23.935B	24.557B
Total Debt	—	—	28.071B	29.100B	28.609B	—	28.516B	26.607B	28.326B
Net Debt (Cash)	—	—	26.924B	27.818B	27.336B	—	26.298B	25.367B	26.932B
Total Shareholders' Equity	—	—	48.985B	48.652B	47.893B	—	48.024B	49.387B	48.494B
Common Stock	—	—	-181.000M	0.00	-28.000M	—	0.00	0.00	0.00
Retained Earnings	—	—	32.303B	32.070B	31.606B	—	31.476B	31.317B	30.919B
Current Ratio	—	—	2.54	2.42	2.01	—	1.85	1.90	1.84
Debt to Equity Ratio	—	—	0.57	0.60	0.60	—	0.59	0.54	0.58

MDT Annual Balance Sheet (USD)

Annual Report	04/24/2026	04/30/2025	04/25/2025	04/30/2024	04/26/2024	04/30/2023	04/28/2023	04/30/2022
Total Current Assets	—	—	23.814B	—	21.935B	—	21.675B	—
Cash & Cash Equivalents	—	—	2.218B	—	1.284B	—	1.543B	—
Short-Term Investments	—	—	6.747B	—	6.721B	—	6.416B	—
Cash & Short-Term Investments	—	—	8.965B	—	8.005B	—	7.959B	—
Accounts Receivable	—	—	6.515B	—	6.128B	—	5.998B	—
Inventory	-404.000M	-292.000M	5.476B	-139.000M	5.217B	-939.000M	5.293B	-560.000M
Total Assets	—	—	91.680B	—	89.981B	—	90.948B	—
Property, Plant & Equipment	—	—	6.837B	—	6.131B	—	5.569B	—
Goodwill	—	—	41.737B	—	40.986B	—	41.425B	—
Intangible Assets	—	—	11.667B	—	13.225B	—	14.844B	—
Long-Term Investments	—	—	0.00	—	0.00	—	0.00	—
Total Current Liabilities	—	—	12.879B	—	10.789B	—	9.051B	—
Accounts Payable	—	—	2.449B	—	2.410B	—	2.662B	—
Short-Term Debt	—	—	2.868B	—	1.086B	—	13.000M	—
Total Liabilities	—	—	43.424B	—	39.561B	—	39.283B	—
Long-Term Debt	—	—	25.590B	—	23.877B	—	24.287B	—
Total Debt	—	—	28.516B	—	25.024B	—	24.364B	—
Net Debt (Cash)	—	—	26.298B	—	23.740B	—	22.821B	—
Total Shareholders' Equity	—	—	48.024B	—	50.214B	—	51.483B	—
Common Stock	—	—	0.00	—	0.00	—	0.00	—
Retained Earnings	—	—	31.476B	—	30.403B	—	30.392B	—
Current Ratio	—	—	1.85	—	2.03	—	2.39	—
Debt to Equity Ratio	—	—	0.59	—	0.50	—	0.47	—

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway

95,000 employees

www.medtronic.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Geoffrey Straub Martha

View full financials